l-r: Andrew McClintock, solicitor; David Rowan, head of corporate; Adam Magill, solicitor; and Matthew Nesbitt, solicitor (Image credit: ALG) Corporate law firm A&L Goodbody (ALG) has appointed three ...
ALG.APV-527 is under clinical development by Alligator Bioscience and currently in Phase II for Metastatic Ovarian Cancer. According to GlobalData, Phase II drugs for Metastatic Ovarian Cancer have a ...
As the global population ages, the prevalence of neurodegenerative disorders is fast increasing. This neurodegeneration as well as other CNS injuries cause permanent disabilities. Thus, generation of ...
SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback